These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Comparison of mid- and high dosage methylprednisolone pulse therapy in chronic polyarthritis].
    Author: Schlumpf U, Hofmann P.
    Journal: Z Rheumatol; 1990; 49(3):160-4. PubMed ID: 2378175.
    Abstract:
    Intravenous pulse methylprednisolone of 1000 mg was compared with 250 mg in patients suffering from rheumatoid arthritis. In this prospective open trial no difference could be observed regarding the number of heavily involved joints, morning stiffness, or blood sedimentation rate 2 weeks and 2 months after use of highdose or intermediate dose intravenous methylprednisolone. Medium remission duration was 6 weeks (2-24 weeks). Side effects occurred only rarely; they were transitory and harmless.
    [Abstract] [Full Text] [Related] [New Search]